Essential medicines and health products

Essential Drugs in Brief

A bulletin on major WHO country and regional work in the field of essential drugs and medicines policy

Essential drugs in brief's purpose is to share information on the latest country support provided or coordinated by the extended Drug Action Programme team. It is an informal instrument aiming to share our experiences with the rest of our colleagues within and outside WHO, who are active in the implementation of national drug policies at national and regional levels.

Issue No.13, June 2004

WTO’s Decision on Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health

Issue No.12, February 2004

Eleventh International Conference of Drug Regulatory Authorities

Issue No.11, November 2003

WHO indicators providing updated information on country pharmaceutical situations

Issue No.10, July 2003

Assessment-based planning and interventions in countries in Africa

Issue No.9, March 2003

World Health Assembly elects new WHO Director-General

Issue No.8, November 2002

Monitoring and assessing country pharmaceutical situations

Issue No.7, July 2002

WHO launched the first global strategy on traditional and alternative medicine at the World Health Assembly, May 2002

Issue No.6, April 2002

Historic Doha Declaration on the TRIPS Agreement and Public Health

Issue No.5, September 2001

TRIPS Workshop for the WHO African Region

Issue No.4, April 2001

South Africa -- Access to essential drugs in international trade agreements

Issue No.3, January 2001

The ways in which WHO support countries

Issue No.2, September 2000

How WHO works with countries on medicines

Issue No.1, June 2000

Why country support?